Tags

Type your tag names separated by a space and hit enter

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
N Engl J Med. 2021 07 29; 385(5):472-474.NEJM

Authors+Show Affiliations

University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.University of Texas Medical Branch, Galveston, TX.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.Pfizer Vaccine Research and Development, Pearl River, NY.BioNTech, Mainz, Germany.BioNTech, Mainz, Germany.Pfizer Vaccine Research and Development, Pearl River, NY.University of Texas Medical Branch, Galveston, TX xuxie@utmb.edu.Pfizer Vaccine Research and Development, Pearl River, NY philip.dormitzer@pfizer.com.University of Texas Medical Branch, Galveston, TX peshi@utmb.edu.

Pub Type(s)

Letter

Language

eng

PubMed ID

33979486

Citation

Liu, Yang, et al. "BNT162b2-Elicited Neutralization Against New SARS-CoV-2 Spike Variants." The New England Journal of Medicine, vol. 385, no. 5, 2021, pp. 472-474.
Liu Y, Liu J, Xia H, et al. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants. N Engl J Med. 2021;385(5):472-474.
Liu, Y., Liu, J., Xia, H., Zhang, X., Zou, J., Fontes-Garfias, C. R., Weaver, S. C., Swanson, K. A., Cai, H., Sarkar, R., Chen, W., Cutler, M., Cooper, D., Muik, A., Sahin, U., Jansen, K. U., Xie, X., Dormitzer, P. R., & Shi, P. Y. (2021). BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants. The New England Journal of Medicine, 385(5), 472-474. https://doi.org/10.1056/NEJMc2106083
Liu Y, et al. BNT162b2-Elicited Neutralization Against New SARS-CoV-2 Spike Variants. N Engl J Med. 2021 07 29;385(5):472-474. PubMed PMID: 33979486.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants. AU - Liu,Yang, AU - Liu,Jianying, AU - Xia,Hongjie, AU - Zhang,Xianwen, AU - Zou,Jing, AU - Fontes-Garfias,Camila R, AU - Weaver,Scott C, AU - Swanson,Kena A, AU - Cai,Hui, AU - Sarkar,Ritu, AU - Chen,Wei, AU - Cutler,Mark, AU - Cooper,David, AU - Muik,Alexander, AU - Sahin,Ugur, AU - Jansen,Kathrin U, AU - Xie,Xuping, AU - Dormitzer,Philip R, AU - Shi,Pei-Yong, Y1 - 2021/05/12/ PY - 2021/5/13/pubmed PY - 2021/8/10/medline PY - 2021/5/12/entrez SP - 472 EP - 474 JF - The New England journal of medicine JO - N Engl J Med VL - 385 IS - 5 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/33979486/BNT162b2_Elicited_Neutralization_against_New_SARS_CoV_2_Spike_Variants_ L2 - https://www.nejm.org/doi/10.1056/NEJMc2106083?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -